SAMWHA ELECTRIC, a Leading Manufacturer of Electrolytic Capacitor, Draws Attention in World Electronics Market
24.4.2020 11:00:00 EEST | Business Wire | Press release
SAMWHA ELECTRIC (KRX:009470), a specialty manufacturer of electrolytic capacitors in Korea, attracts attention in the world electronics market by launching a conductive polymer hybrid electrolytic capacitor built on advanced technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200424005097/en/
SAMWHA ELECTRIC, a specialty manufacturer of electrolytic capacitors in Korea, attracts attention in the world electronics market by launching a conductive polymer hybrid electrolytic capacitor built on advanced technology. SAMWHA ELECTRIC has been providing the global market with its electric double layer capacitor ‘Green-Cap’ used for eco-friendly high-valued products, such as 5G, eco-friendly vehicles, medical devices, LED, robots, Internet-of-Things (IoT), and energy storage systems (ESSs) for wind and solar power for many years. Thanks to a long replacement cycle based on fast charge/discharge cycles for over 1 million times, Green-Cap is easy to maintain and it can be used in extreme temperatures. As it does not contain environmentally hazardous substances, it is also easy to treat after use. (Graphic: Business Wire)
SAMWHA ELECTRIC has been providing the global market with its electric double layer capacitor ‘Green-Cap’ used for eco-friendly high-valued products, such as 5G, eco-friendly vehicles, medical devices, LED, robots, Internet-of-Things (IoT), and energy storage systems (ESSs) for wind and solar power for many years.
Thanks to a long replacement cycle based on fast charge/discharge cycles for over 1 million times, Green-Cap is easy to maintain and it can be used in extreme temperatures. As it does not contain environmentally hazardous substances, it is also easy to treat after use.
With increasing demand in strategic markets including electric vehicles, communication, smart consumer electronics, renewable energies, UPS, automotive industry and electronic components, orders for the product is growing worldwide. Through its five sales subsidiaries in Germany, the United States, China, Thailand and India as well as 14 major regional offices in other countries, the company has built stable international business infrastructure to lead the global market.
Expecting brighter future in line with expansion in eco-friendly automotive infrastructure and increase in demand for eco-friendly power due to expanded environment regulation policies, SAMWHA ELECTRIC aims to meet demands for high-specification products by developing high-valued devices at its corporate R&D center and to take an advantageous position while transforming into a leading electronic component company by developing proprietary technologies.
“In order to grow into an integrated electronic parts maker through systematic quality control, we are implementing management systems in three stages, and effectively managing production processes with enterprise resource planning (ERP), a real-time data management system, and manufacturing execution system (MES),” said a manager at SAMWHA ELECTRIC.
Backed by these efforts, SAMWHA ELECTRIC is further advancing into the global market with synergies of designation as one of beneficiaries of support program of the Korea Trade-Investment Promotion Agency (KOTRA). The company also values shared growth with affiliates by establishing partnership relations. The corporate culture of SAMWHA ELECTRIC that shares values with clients has potential for further development with their trust.
Products by SAMWHA ELECTRIC
- EDLC (Electric Double Layer Capacitor) for Radial, Snap-in, Axial Type & Module
- Conductive Polymer Hybrid Aluminum Electrolytic Capacitor for Radial, SMD Type
- Aluminum Electrolytic Capacitor for Radial, SMD, Snap-in, Lug, Screw Type
Main Application
- Household Appliance for High Ripple Current, Miniaturization and Long Life
- Solar Power Inverter for High Voltage, High Capacitance and High Ripple Current
- Power Electronics for High Capacitance, High Ripple Current and Long Life and Power Industry, Plant Business, Infrastructure Business Segment
- Led Lighting for Ultra-High Temperature, Long Life and Low Impedance
- Automotive for powertrain (ECU, DC/DC Converter), Safety (Breaking, Airbag, ABS) and Exterior (LED Headlight)
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200424005097/en/
Contact information
SAMWHA Electric H.Q.
Mr. Yong Dong Kim
+82-2-2056-1646
sesale1@samwha.com
SAMWHA EUROPE GmbH
Mr. Kwang Hyun Park
+49-0-69-9637-65-0
europe@samwha.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom